Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2026-04-21 09:13:37 ET · period of report 2026-04-19 · accession 0001193125-26-165304 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-21 09:13 | 2026-04-19 | HRTX | Duarte Ira | EVP, CFO | M - OptEx | — | +3,874 | 215.9K | +2% | — |
| D | 2026-04-21 09:13 | 2026-04-19 | HRTX | Duarte Ira | EVP, CFO | M - OptEx | $0.00 | -3,874 | 27.1K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-19 | M | A | 3,874 | — | 215,876 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F2) Includes 16,646 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2025. |
| 2 | Derivative | Restricted Stock Units | 2026-04-19 | M | D | 3,874 | $0.00 | 27,120 | D | $0.00 · — to — | 3,874 Common Stock | (F3) The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024). (F3) The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024). |